RT Journal Article
SR Electronic
T1 Modelling testing and response strategies for COVID-19 outbreaks in remote Australian Aboriginal communities
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.07.20208819
DO 10.1101/2020.10.07.20208819
A1 Ben B. Hui
A1 Damien Brown
A1 Rebecca H. Chisholm
A1 Nicholas Geard
A1 Jodie McVernon
A1 David G. Regan
YR 2020
UL http://medrxiv.org/content/early/2020/10/09/2020.10.07.20208819.abstract
AB Background Remote Australian Aboriginal and Torres Strait Islander communities have potential to be severely impacted by COVID-19, with multiple factors predisposing to increased transmission and disease severity. Our modelling aims to inform optimal public health responses.Methods An individual-based simulation model represented communities ranging from 100 to 3,500 people, comprised of large interconnected households. A range of strategies for case finding, quarantining of contacts, testing, and lockdown were examined, following the silent introduction of a case.Results Multiple secondary infections are likely present by the time the first case is identified. Quarantine of close contacts, defined by extended household membership, can reduce peak infection prevalence from 60-70% to around 10%, but subsequent waves may occur when community mixing resumes. Exit testing significantly reduces ongoing transmission.Concurrent lockdown of non-quarantined households for 14 days is highly effective for epidemic control and reduces overall testing requirements; peak prevalence of the initial outbreak can be constrained to less than 5%, and the final community attack rate to less than 10% in modelled scenarios. Lockdown also mitigates the effect of a delay in the initial response. Compliance with lockdown must be at least 80-90%, however, or epidemic control will be lost.Conclusions A SARS-CoV-2 outbreak will spread rapidly in remote communities. Prompt case detection with quarantining of extended-household contacts and a 14-day lockdown for all other residents, combined with exit testing for all, is the most effective strategy for rapid containment. Compliance is crucial, underscoring the need for community supported, culturally sensitive responses.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialN/A (not a clinical trial)Funding StatementThis work was supported by the National Health and Medical Research Council through Centre of Research Excellence (GNT1170960). JMcV is supported by a NHMRC Principal Research Fellowship (GNT1117140). None of the funding bodies were or will be involved in the study design, model analysis, interpretation of findings and manuscript writing.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethnical approval is required as it is a modelling study relying purely from publicly available or hypothetical data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe modelling code is publicly available at Zendo/GitHub at the following DOI: https://doi.org/10.5281/zenodo.4057288 https://doi.org/10.5281/zenodo.4057288 COVID-19Coronavirus Disease 2019H1N1Influenza A virus subtype H1N1IAGAboriginal and Torres Strait Islander Advisory Group on COVID-19ICUIntensive care unitsSARS-CoV-2Severe acute respiratory syndrome coronavirus 2